Zinc Patents (Class 514/494)
-
Publication number: 20040259937Abstract: Described are tri-, tetra-, and penta-metal complex salts of hydroxycitric acid, compositions containing the same, and methods of making the same, where the salt comprises at least three different metals selected from zinc, magnesium, sodium, potassium, and calcium.Type: ApplicationFiled: April 13, 2004Publication date: December 23, 2004Applicant: INDFRAG LIMITEDInventors: Philip Samuel, Somasundaram Saravanan, Meyyappan Thangaraj
-
Patent number: 6833362Abstract: A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or “pseudo” enzymes for the oxidation. Additives include the oxidant Nicotinamide Adenine Dinucleotide and a variety of other additives such as transition metal ions and complexes thereof which favor the oxidation reaction. The compositions described can act as a sobriety inducer and/or as an effective palliative for the unpleasant effects of overuse of ethanol.Type: GrantFiled: June 7, 2001Date of Patent: December 21, 2004Inventors: Ward Beryl Bowen, Jr., Daniel Salman Daniel
-
Publication number: 20040254239Abstract: Metal L-seleno-alpha-amino acids salts and their use as a bioavailable feed and water ration supplement for domesticated animals such as cattle, pigs and poultry.Type: ApplicationFiled: February 21, 2003Publication date: December 16, 2004Applicant: Zinpro CorporationInventors: Mahmoud M. Abdel-Monem, Michael D. Anderson
-
Publication number: 20040229300Abstract: The present invention provides a method of determining if an individual is at risk for prostate cancer. The method measures and compares zinc levels in a semen sample in the potential at risk individual with normal levels. A decrease in zinc level is indicative of a risk for prostate cancer. Further provided is a zinc-based diagnostic kit for prostate cancer.Type: ApplicationFiled: April 22, 2004Publication date: November 18, 2004Inventor: Christopher J. Frederickson
-
Publication number: 20040219227Abstract: Antimicrobial compositions having synergistic combinations of octoxyglycerin and at least one other antimicrobial agent in formulations which are more effective than prior art compositions without causing increased irritation to the skin of the average user. In certain embodiments, skin irritation may be minimized by low concentrations of antimicrobials and/or the presence of soothing compounds such as zinc. Preferred embodiments include combinations of octoxyglycerin, a quaternary compound, and at least one other antimicrobial agent. Without being bound to any particular theory, it is hypothesized that the unexpected antimicrobial effectiveness of combinations of octoxyglycerin may result from an enhancement of the permeability of microbes to antimicrobials caused by octoxyglycerin. Hydroalcoholic gel composition containing alcohol, water, hydrogel, and emollient or emulsifier, wherein the composition has a viscosity of below 2000 centipoises at between 20 and 40° C.Type: ApplicationFiled: February 25, 2004Publication date: November 4, 2004Inventors: Shanta Modak, Trupti A. Gaonkar
-
Publication number: 20040192587Abstract: Prophylactic treatment to reduce the incidence of common cold using formulations of zinc compounds with selected amino acids is described. The administration of such formulations to healthy individuals resulted in a statistically significant reduction in the incidence of common colds in healthy patients.Type: ApplicationFiled: April 23, 2002Publication date: September 30, 2004Inventors: Richard A. Rosenbloom, Charles A. Phillips
-
Publication number: 20040180084Abstract: The invention relates to a composition that contains the most potent combination of nutrients proven to assist in the treatment and prevention of cardiovascular disease, stroke, Alzheimer's disease and neurological degeneration by lowering elevated homocysteine levels. The present invention involves a composition for oral ingestion that contains essential amounts of Vitamin B6(Pyroxidine HCL and Pyridoxal 5-Phosphate), Folic Acid(folacin), Vitamin B12(Methylcobalamin), Zinc(Zinc L-monomethionine), N-acetyl Cysteine, and Inositol, as well as other ingredients and healthy filler ingredients.Type: ApplicationFiled: March 12, 2003Publication date: September 16, 2004Inventor: Wayne F. Gorsek
-
Patent number: 6784319Abstract: Compositions comprising (±)-2-((dimethylamino)methyl)cyclohexanone, a transition-metal salt, and an organic solvent and methods of preparing (±)-cis-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols, in particular (±)-cis-2-((dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol, are disclosed herein. In one embodiment, the (±)-2-((dimethylamino)methyl)cyclohexanone and transition-metal salt are in the form of a (±)-2-((dimethylamino)methyl)cyclohexanone:transition-metal salt complex. In another embodimemt, aryl is 3-methoxyphenyl.Type: GrantFiled: September 15, 2003Date of Patent: August 31, 2004Assignee: Euro-Celtique, S.A.Inventors: Robert J. Kupper, Andreas Stumpf
-
Publication number: 20040167114Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.Type: ApplicationFiled: January 16, 2004Publication date: August 26, 2004Inventor: Henry Fliss
-
Publication number: 20040162341Abstract: This invention relates to salts of sulfodehydroabietic acid with bismuth or zinc, a kind of new salt useful in treating digestive canal ulcer, acute & chronic gastritis, and erosive gastritis etc., as well as its preparation and use. Said salts can be represented by formula (1), wherein R is Bi(OH)++ or Zn++, 2Bio+, 1/2ZnH, n=0-10. The preparation method comprises following steps: (a) sequentially treating the industrial abietic acid calcium salt with acid, base and extracting with organic solvent to give abietic acid with less isomer; (b) reacting said abietic acid with Pd/C to provide dehydroabietic acid, then converting it to pure sulphonic product, namely sulfodehydroabietic acid, via sulphonation and recrystallization; (c) by use of neutralization or salt displacement reaction to convert the sulphonic product of zinc or bismuth salts of sulfodehydroabietic acid. The resultant salts can used to prepare medicine for treating digestive canal ulcer and gastritis.Type: ApplicationFiled: January 14, 2004Publication date: August 19, 2004Inventors: Liangyuan Zheng, Shiwei Zhang, Li Zheng, Mingxin Wang, Yongli Zhao, Xuezhao Lu, Yongli Zhao
-
Publication number: 20040157921Abstract: Methods of altering properties of tissues, by providing an effective modifying amount of zinc, which may be in the form of zinc ions. This is accomplished through the use of topical compositions containing one or more zinc-containing components such as salts and/or other zinc compounds or complexes, particularly zinc acetate.Type: ApplicationFiled: October 22, 2003Publication date: August 12, 2004Applicant: Essentia Biosystems, Inc.Inventors: Pamela Cifra, Michael D. Dake, Christopher Elkins, Jacob M. Waugh
-
Patent number: 6770674Abstract: A mollusc repellent, which includes a substantially insoluble metal oxalate and a suitable carrier therefor, which exhibits prolonged efficacy. The mollusc repellent is environmentally friendly, being both non-phytotoxic and harmless to non-target animals, and is therefore suitable for use in sustainable agriculture, where the use of toxic chemicals is unacceptable. The mollusc repellent can be used in the form of a solid or as a coating composition.Type: GrantFiled: February 9, 2001Date of Patent: August 3, 2004Inventor: Colin Leslie Young
-
Patent number: 6764692Abstract: A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administering to a horse in need thereof, effective amounts of a naturally chelated trace mineral composition. A method of preparing the chelated trace mineral composition from ocean seabed rock is further disclosed, as well as the chelated trace mineral composition.Type: GrantFiled: August 27, 2002Date of Patent: July 20, 2004Inventor: Carlos Cortelezzi
-
Publication number: 20040131700Abstract: Implantable medical devices using zinc, and methods therefore, provide one or more advantageous effects to a tissue. In one embodiment, at least one zinc-containing component is coupled with a stent via one or more zinc chelators to enhance resistance of the stent to plaque formation and in-stent restenosis. Elastin production may also be enhanced by devices coupled with zinc. Enhanced elastin production may be used, for example, to treat a blood vessel in location at or near an aneurysm. In some embodiments, both elastin production and plaque resistance are enhanced. For example, zinc may be applied via a gel or other carrier substance to a venous graft for enhancing elastin and resisting plaque formation. Implantable devices coupled with zinc may provide improved results of medical and surgical procedures involving implantable devices, thus reducing the need for repeat procedures.Type: ApplicationFiled: October 22, 2003Publication date: July 8, 2004Applicant: Essentia Biosystems, Inc.Inventors: Pamela Cifra, Michael D. Dake, Christopher Elkins, Jacob M. Waugh
-
Patent number: 6756063Abstract: Methods and compositions for altering the viability of cells, particularly cancers in animals and humans are disclosed. The compositions of the present invention are formed from a set of components comprising one or more of the following: a dithiocarbonyl, preferably dithiocarbamate, compound; a divalent metal ion; a modulator of cellular glutathione levels; and an inhibitor of the phosphorylation of choline. The compositions described herein induce a relatively selective and rapid effect on the viability of cancer cells by inducing a mixture of apoptotic and necrotic cell death, with the dominant pathway being apoptosis. Particularly preferred active compositions comprise all four components, although combinations of fewer components can be fully effective in certain tumors.Type: GrantFiled: May 24, 2001Date of Patent: June 29, 2004Assignee: Zoltan Laboratories, LLCInventor: Zoltan Kiss
-
Publication number: 20040122088Abstract: A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a zinc-cysteine complex. The zinc-cysteine complex is preferably a zinc-monocysteine complex. The complexes of zinc-cysteine of the present invention increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein. The complexes of zinc-cysteine of the present invention protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations.Type: ApplicationFiled: June 30, 2003Publication date: June 24, 2004Inventors: David A. Newsome, David Tate
-
Publication number: 20040109902Abstract: Aqueous preparations of substantially equimolor amounts of a zinc salt and clindamycin phosphate form a polymer useful in the topical treatment of acne and rosacea, with very low systemic levels of clindamycin.Type: ApplicationFiled: January 28, 2004Publication date: June 10, 2004Inventors: Emma Louise McDonagh, Rebecca Louise Kanis
-
Publication number: 20040102429Abstract: The addition of low concentrations of combinations of water-soluble organic salts of zinc to gels, creams, lotions or ointments can increase the ability of these products to reduce or prevent exogenous irritants from causing irritation of the underlying substrate. The addition of low concentrations of combinations of water-soluble organic zinc salts to these gels, creams, lotions or ointments also can reduce the irritation of skin or mucous membranes caused by the addition of potentially-irritating substances such as spermicides, microbicides, fungicides or other therapeutic agents to the gel, cream, lotion or ointment. The advantages of this anti-irritant approach over others, which generally employ high concentrations of single zinc salts, are the reduced potential for zinc toxicity, the reduced potential for toxicity related to zinc itself, and the preservation of the desirable biological properties of potentially-irritating therapeutic substances added to the gel, cream, lotion or ointment.Type: ApplicationFiled: July 17, 2003Publication date: May 27, 2004Inventors: Shanta M. Modak, Milind S. Shintre, Lauser Caraos, Trupti Gaonkar
-
Patent number: 6737419Abstract: Stable tablets comprising benazepril hydrochloride are prepared by employing zinc stearate as the lubricant.Type: GrantFiled: April 12, 2002Date of Patent: May 18, 2004Inventor: Bernard Charles Sherman
-
Publication number: 20040092586Abstract: A novel a-lipoic acid derivative represented by the following formula (I). It has tyrosinase inhibitory activity, melanin production inhibitory activity, and elastase inhibitory activity. (I) (In the formula, M represents a metal and A represents an amino acid residue bonded through the nitrogen atom.).Type: ApplicationFiled: September 17, 2003Publication date: May 13, 2004Inventors: Kazumi Ogata, Takahiro Sakaue, Kazuhiko Ito
-
Publication number: 20040086575Abstract: Disclosed are anti-viral compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating lesionous symptoms of a viral infection involving applying an effective amount of the anti-viral composition to the lesions.Type: ApplicationFiled: November 4, 2002Publication date: May 6, 2004Inventor: Jeffrey B. Smith
-
Publication number: 20040086463Abstract: The invention provides for a nasal spray which is an aqueous solution containing a broad spectrum microbicide which may be applied in nasal passages in the manner of a decongestant type nose spray in the event of known or suspected exposure of the individual to common cold virus, flu, or other infective microbial agents. The solution contains active agents which are based on a chlorine or hypochlorite solution, or a solution of chlorine or hypochlorite plus a salt of chloride, bromide or iodide. Alternatively, the solution may contain a bromine solution, or a solution of bromine plus a salt of chloride, bromide or iodide such as sodium chloride, zinc chloride, sodium bromide, zinc bromide, sodium iodide or zinc iodide. The chlorine, hypochlorite, bromine, chloride, bromide, and iodide may originally come from inorganic compounds or organic compounds, which are then dissolved in the water. Further, the solution may contain glycerin or another moisturizing or wetting agent for the nasal mucosa.Type: ApplicationFiled: October 21, 2003Publication date: May 6, 2004Inventor: Richard L. Hansen
-
Patent number: 6730329Abstract: One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one analgesic) at least one hydrocarbyl containing compound, and water. Another aspect of the invention relates to a method of treating lesionous symptoms of a viral infection involving applying an effective amount of the zinc containing anti-viral composition to the lesions.Type: GrantFiled: February 26, 2002Date of Patent: May 4, 2004Inventor: Jeffrey B. Smith
-
Publication number: 20040077620Abstract: A zinc(II) complex which is lowly toxic, has high insulin-like activity, and is effectively usable as a hypoglycemic agent for the prevention or treatment of diabetes; a hypoglycemic agent containing the complex; a medicinal preparation which contains the complex and is useful as a preventive/remedy for diabetes; and a food containing the complex, such as a health food or supplementary health food. The hypoglycemic agent contains an organic zinc(II) complex having as a ligand a compound selected among aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, &agr;- and &bgr;-hydroxycarboxylic acids, vitamins, glutamine derivatives, etc.Type: ApplicationFiled: July 29, 2003Publication date: April 22, 2004Inventors: Yoshitane Kojima, Hiromu Sakurai, Yutaka Yoshikawa
-
Publication number: 20040077714Abstract: Neutral alpha amino diacid complexes of trace minerals and their use for animal nutrition.Type: ApplicationFiled: October 16, 2002Publication date: April 22, 2004Applicant: Zinpro CorporationInventors: Mahmoud M. Abdel-Monem, Michael D. Anderson
-
Publication number: 20040077619Abstract: The compounds of the invention are represented by the following general structure 1Type: ApplicationFiled: May 22, 2003Publication date: April 22, 2004Inventors: Michael G. Kelly, Shimin Xu, Ning Xi, Robert Townsend, David Semin, Chiara Ghiron, Thomas Coulter
-
Publication number: 20040058011Abstract: A non-toxic, germicide, fungicide and healing composition and a method of topically applying the composition in powdered form to the skin of domesticated farm animals including dairy cattle are disclosed. The composition comprises (a) finely divided, particulate chlorhexidine-containing material, (b) finely divided, particulate zinc-containing material and (c) an inert powdered carrier, with the chlorhexidine-containing material and the zinc-containing material being present in an amount to achieve effective germicidal activity. The chlorhexidine-containing material is preferably chlorhexidine acetate. The zinc-containing material is preferably selected from the group consisting of zinc stearate, zinc chloride, zinc nitrate, zinc oleate, zinc oxide, zinc phosphate, zinc peroxide, zinc iodide, elemental zinc and mixtures thereof.Type: ApplicationFiled: September 10, 2003Publication date: March 25, 2004Inventor: Lennart G. Petersson
-
Patent number: 6710079Abstract: A composition and method of preparing amino acid chelates and complexes free of interfering ions by blending an amino acid ligand, a calcium oxide and/or hydroxide, and a hydrated metal sulfate salt, placing the blend in a closed environment, heating the blend, and allowing the blend to react is disclosed and described. By heating at low to moderate temperatures in an enclosed environment, the waters of hydration of the metal salt are retained in the enclosed environment and serve to provide the moisture necessary to enable a bonding reaction to take place between the electron rich functional groups of the ligand and the metal ion of the hydrated metal sulfate salt. Additionally, calcium sulfate is formed which can be maintained in the final product.Type: GrantFiled: October 11, 2000Date of Patent: March 23, 2004Assignee: Albion International, Inc.Inventors: H. DeWayne Ashmead, Stephen D. Ashmead, David C. Wheelwright, Clayton Ericson, Mark Pedersen
-
Patent number: 6693094Abstract: The invention describes formulations that include either metformin, sulfonylurea or a biguanide-sulfonylurea combination as one active ingredient in addition to specific, other active ingredients. The compositions and dosage forms of the invention are clinically useful as methods for increasing the effectiveness, efficiency and safety of the included biguanide (metformin) and/or sulfonylurea in the prevention and treatment of insulin resistance and diabetes mellitus. The carefully chosen additional active ingredients of the invention are designed in a modular fashion to prevent and rectify adverse events associated with insulin resistance syndrome and diabetes mellitus, and those adverse incidences associated with the concurrent use of metformin and/or the sulfonylureas. When clinically administered, the invention will provide therapeutic levels of metformin and of a sulfonylurea, alone or in combination, and broaden their usefulness.Type: GrantFiled: March 7, 2002Date of Patent: February 17, 2004Assignee: Chrono RX LLCInventors: Don C. Pearson, Kenneth T. Richardson
-
Publication number: 20040029961Abstract: This invention relates to a composition for controlling fungal growth comprising a carrier and a salt of formic acid.Type: ApplicationFiled: April 7, 2003Publication date: February 12, 2004Inventors: James Richard Von Krosigk, Thomas E. Peterson
-
Patent number: 6689392Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.Type: GrantFiled: January 29, 2002Date of Patent: February 10, 2004Assignee: Agricare Ltd.Inventor: Ran Lifshitz
-
Patent number: 6686392Abstract: A method for making a composition containing a fatty acid or fatty ester compound and zinc. The compositions produced by the method. Administration of these compositions to a patient to increase the zinc content of cells or tissue having a zinc deficiency or to treat at least some of the symptoms of diseases or adverse effects caused by this zinc deficiency.Type: GrantFiled: October 1, 2002Date of Patent: February 3, 2004Inventor: Elena Avram
-
Publication number: 20040006055Abstract: Compounds that demonstrate chelation affinity and selectivity for first transition series elements are administered to patients suffering from such conditions as ischemia, prolonged seizures and trauma to provide neuroprotection, cardioprotection, or both. These compounds when administered form complexes with chelatable iron and copper cations and thereby mitigate the ability of these cations to catalyze Haber-Weiss reactions that form toxic hydroxy free radicals that cause tissue injury. These compounds also form complexes with chelatable zinc cations thereby inhibiting the cytotoxicity associated with excess chelatable zinc.Type: ApplicationFiled: June 13, 2002Publication date: January 8, 2004Applicants: CONCAT, LTD. a California Limited Partnership, CHELATOR LLC., a Delaware corporationInventor: Harry S. Winchell
-
Patent number: 6673835Abstract: A viscous gel for delivering minor effective amounts of active substances through the nasal membrane into the body.Type: GrantFiled: September 1, 1999Date of Patent: January 6, 2004Assignee: Zicam LLCInventors: Charles Hensley, Robert Steven Davidson
-
Publication number: 20030232098Abstract: Therapeutic compositions for the treatment of tinnitus are described which contain effective amounts of Ginkgo biloba, garlic and zinc. In formulations containing greater than 50 mg of zinc, the composition may further contain copper. Methods of treating patients having tinnitus include prescribing effective daily doses of the therapeutic compositions of the present invention over a sixty to ninety day period to maximize improvement in the condition, followed by a daily regimen of the therapeutic compositions.Type: ApplicationFiled: June 11, 2003Publication date: December 18, 2003Inventor: Barry Keate
-
Patent number: 6664289Abstract: The invention provides for a nasal spray which is an aqueous solution containing a broad spectrum microbicide which may be applied in nasal passages in the manner of a decongestant type nose spray in the event of known or suspected exposure of the individual to common cold virus, flu, or other infective microbial agents. The solution contains active agents which are based on a chlorine or hypochlorite solution, or a solution of chlorine or hypochlorite plus a salt of chloride, bromide or iodide. Alternatively, the solution may contain a bromine solution, or a solution of bromine plus a salt of chloride, bromide or iodide such as sodium chloride, zinc chloride, sodium bromide, zinc bromide, sodium iodide or zinc iodide. The chlorine, hypochlorite, bromine, chloride, bromide, and iodide may originally come from inorganic compounds or organic compounds, which are then dissolved in the water. Further, the solution may contain glycerin or another moisturizing or wetting agent for the nasal mucosa.Type: GrantFiled: May 6, 2002Date of Patent: December 16, 2003Inventor: Richard L. Hansen
-
Publication number: 20030228382Abstract: A topical antifungal, antimicrobial and antibacterial formulation and kit and a method of use includes the steps of combining an oil extract of melaleuca alternifolia and an oil extract of eucalyptus australiana in each of four formulations wherein, the first one of the four formulations is prepared by further combining ethanol, ethoxylated castor oil, and zinc phenosulphonate; the second one of the four formulations is prepared by further combining petrolatum, ethoxylated castor oil, jojoba oil, aloe vera and lanolin, glyceryl stearate, and octyl stearate; the third one of the four formulations is prepared by further combining ethoxylated castor oil, at least one lauryl sulphate, coccabetaine, and coconut diethanolamine; and the fourth one of the four formulations is prepared by further combining petrolatum, jojoba oil, aloe vera and lanolin.Type: ApplicationFiled: June 6, 2003Publication date: December 11, 2003Inventor: Ivar Edward Roth
-
Patent number: 6656925Abstract: This invention relates to the compositions and method of treating and preventing arthritis, repairing of articular joint surfaces and the relief of symptoms associated with arthritis. The composition comprises bio-affecting agents to reduce nitric oxide production and increase chondroprotective agents. The preferred composition comprises; nitric oxide synthase inhibitors, nitric oxide scavangers, and amino sugars. Nitric oxide synthase inhibitors and nitric oxide scavengers reduce the level of nitric oxide, the free radical responsible for the degradation of articular cartilage. Amino sugars are the building blocks of articular cartilage and have anti-inflammatory actions.Type: GrantFiled: February 5, 2002Date of Patent: December 2, 2003Assignee: Advanced Medical InstrumentsInventor: Edward J. Petrus
-
Publication number: 20030213401Abstract: A material and method for treating timber. The material comprises a preservative and a carrier. The carrier is selected such that it remains mobile within the wood and provides for migration of the preservative within the treated wood. By providing a carrier which is mobile within the wood, the timber has a ‘self healing’ effect wherein the carrier/preservative migrates to any freshly cut or exposed surface of the wood to thereby redistribute and treat such a surface within the preservative and hence maintain integrity of a treatment envelope surrounding the wood.Type: ApplicationFiled: June 13, 2003Publication date: November 20, 2003Applicant: Koppers-Hickson Timber Protection Pty LimitedInventor: Peter Ravnor Soundy Cobham
-
Patent number: 6649783Abstract: Compositions comprising (±)-2-((dimethylamino)methyl)cyclohexanone, a transition-metal salt, and an organic solvent and methods of preparing (±)-cis-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols, in particular (±)-cis-2-((dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol, are disclosed herein. In one embodiment, the (±)-2-((dimethylamino)methyl)cyclohexanone and transition-metal salt are in the form of a (±)-2-((dimethylamino)methyl)cyclohexanone:transition-metal salt complex. In another embodimemt, aryl is 3-methoxyphenyl.Type: GrantFiled: October 3, 2001Date of Patent: November 18, 2003Assignee: Euro-Celtique, S.A.Inventors: Robert J. Kupper, Andreas Stumpf
-
Patent number: 6638431Abstract: A formulation and method to treat and control microbial growth present in the water of climate control systems such as air conditioner air handlers, dehumidifiers, and humidifiers, which formulation can be entrained and dispersed into to living space air. Specifically, a formulation is provided in the form of a tablet or a spray for being applied onto a wetted surface element present in these systems which will effectively control the growth of microbes such as fungus, molds, bacteria, and virus present on the surface for an extended period of time. The formulations include at least two metals, at least two chelating agents, at least one surfactant, and at least one viscosity enhancing compound.Type: GrantFiled: May 3, 2001Date of Patent: October 28, 2003Assignee: Mainstream Engineering CorporationInventors: Dwight D. Back, Robert P. Scaringe, John A. Meyer
-
Publication number: 20030199430Abstract: Prophylactic treatment to reduce the incidence of common cold using formulations of zinc compounds with selected amino acids is described. The administration of such formulations to healthy individuals resulted in a statistically significant reduction in the incidence of common colds in healthy patients.Type: ApplicationFiled: April 23, 2002Publication date: October 23, 2003Inventors: Richard A. Rosenbloom, Charles A. Phillips
-
Patent number: 6630172Abstract: Disinfectant formulations are described which are preferably ecologically friendly and non-toxic to mammals and plants, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having at least one metal ion which is microbicidal to at least one microorganism and potassium sodium tartrate in some form. When potassium sodium tartrate is used with these metal ions, it enhances the complex-forming properties of such metal complexes while concurrently increases their efficacy and potency at the same level of metal ion concentrations. These microbicidal formulations can be diluted in suitable proportions into aqueous systems to produce the desired dosages for each individual case, depending on the level and the severity of the contamination. The microbicidal formulations can be applied by conventional methods, e.g., spraying, soaking, fogging, impregnation, and the like.Type: GrantFiled: January 22, 2001Date of Patent: October 7, 2003Inventor: Kareem I. Batarseh
-
Publication number: 20030165457Abstract: A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory suppressor selected from the group consisting of alpha-keto acids and their salts which reduce the undesired inflammatory response and is an antioxidant. The inflammatory suppressor may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response such as pain, swelling, erythema, crusting, scarring, itching, also disclosed.Type: ApplicationFiled: September 11, 2001Publication date: September 4, 2003Inventor: Alain Martin
-
Patent number: 6613800Abstract: A method and composition for treating psoriasis, eczema, seborrheic dermatitis, and possibly arthritis. The present invention involves treatment of these conditions with an oral administration of a mixture comprised of three primary ingredients: fumaric acid and/or fumarate compounds, inorganic nickel compound(s) such as nickel sulfate, and inorganic bromide compound(s) such as potassium bromide.Type: GrantFiled: December 3, 2001Date of Patent: September 2, 2003Inventor: Steven A. Smith
-
Publication number: 20030158171Abstract: A method for reducing alcohol desire or dependency in a human can comprise the steps of administering a chelate or a combination of chelates to a human having alcohol dependency symptoms or an unwanted desire for alcohol. Ligands that can be used include carnitine, naturally occurring amino acids, and various thiamine molecules. Metals that can be used include nutritionally relevant metals, including copper, zinc, and manganese, to name a few.Type: ApplicationFiled: November 26, 2002Publication date: August 21, 2003Applicant: Albion International, inc.Inventors: H. DeWayne Ashmead, R. Charles Thompson
-
Patent number: 6608043Abstract: The present invention provides an agent for treatment of arthritic diseases such as rheumatoid arthritis that has for its active ingredient a complex of hyaluronic acid and zinc. This complex synergistically inhibits proliferation of synovial cells and suppresses matrix metalloproteinase MMP-9, which is produced by synovial cells, as compared with its constituents, hyaluronic acid and zinc, alone.Type: GrantFiled: September 7, 2001Date of Patent: August 19, 2003Assignees: Takata Seiyaku Co., Ltd., Richter Gedeon Vegyeszeti Gyar Rt.Inventors: Isao Serizawa, Keisei Maekawa, Janos Illes, Erzsebet Neszmeli
-
Patent number: 6586611Abstract: A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a zinc-cysteine complex. The zinc-cysteine complex is preferably a zinc-monocysteine complex. The complexes of zinc-cysteine of the present invention increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein. The complexes of zinc-cysteine of the present invention protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations.Type: GrantFiled: January 8, 2001Date of Patent: July 1, 2003Inventors: David A. Newsome, David Tate
-
Patent number: 6579904Abstract: Betaine transition metal complexes are formed by: a) reacting a solution including an alkali metal salt of chloroacetic acid with a solution including the transition metal salt to give a solution including a chloroacetate transition metal complex; and b) reacting the solution including the chloroacetate transition metal complex with trimethylamine to give a solution including the betaine transition metal complex. Such betaine transition metal complexes may be used as a feed supplement for animals in the process of preparing such animals for market.Type: GrantFiled: September 22, 2000Date of Patent: June 17, 2003Assignee: K.E.R. Associates, Inc.Inventors: Harvey B. Hopps, Gary Culp, Steven B. Malcolm, Ken W. Ridenour, Jay Thurman
-
Publication number: 20030109512Abstract: A method of increasing testosterone level in humans by topical application of a cream or gel involves the use of an androgenic testosterone precursor and a protein precursor for elevating the symptoms of depression and lethargy associated with low level testosterone. The androgenic precursor is 4-androstenediol, the protein precursor is 5-hydroxytryptophan. The two active ingredients are mixed in therapeutically effective amounts with a penetrating cream or gel containing a formulation of lecithin, isopropyl palmitate, and pluronic.Type: ApplicationFiled: October 29, 2002Publication date: June 12, 2003Inventors: Andrew Kucharchuk, Merrill A. Patin